Skip to main content
. 2023 Apr 12;55(1):2190618. doi: 10.1080/07853890.2023.2190618

Table 1.

Univariate and multivariate COX analysis.

Characteristics Total (N) Univariate analysis
Multivariate analysis
Hazard ratio (95% CI) p Value Hazard ratio (95% CI) p Value
T stage 241        
T1 138 Reference      
T2 72 1.109 (0.477–2.578) 0.810 0.000 (0.000-Inf) 0.999
T4 10 10.411 (4.231–25.618) <0.001    
T3 21 3.251 (1.274–8.292) 0.014 2.470 (0.268–22.747) 0.425
N stage 193        
N0 133 Reference      
N1 60 3.544 (1.572–7.987) 0.002 3.319 (0.967–11.398) 0.057
M stage 125        
M0 114 Reference      
M1 11 4.290 (1.401–13.137) 0.011 0.025 (0.000-Inf) 1.000
Clinical stage 295        
Stage I 158 Reference      
Stage II 69 0.895 (0.417–1.921) 0.776 0.000 (0.000-Inf) 0.999
Stage III 46 1.570 (0.732–3.366) 0.247 0.000 (0.000-Inf) 0.999
Stage IV 22 5.109 (2.559–10.199) <0.001    
Age 302        
< =50 186 Reference      
>50 116 1.295 (0.761–2.204) 0.340    
Histological type 302        
Adenosquamous 52 Reference      
Squamous cell carcinoma 250 0.983 (0.481–2.011) 0.963